Artificial intelligence is entering the era of self-improvement. On Thursday afternoon, OpenAI released a new cutting-edge coding model that the company said assisted in its own creation.

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $3.90, marking a -4.88% move from the previous day. The stock fell short of the S&P 500, which registered a loss of 0.51% for ...

Market breadth has hit at least a five-year low during Sunday’s budget session, with four out of every five BSE 500 stocks retreating. This marks the most widespread sell-off on a budget day since ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.32, marking a -3.36% move from the previous day. This change lagged the S&P 500's daily loss of 0.13%. On the other hand, ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, ...

IO Interactive's James Bond simulator 007 First Light has been delayed until May 27, 2026. It was supposed to come out in March. The company says two-month delay is for polish and refinement, which is ...

Dec 8 (Reuters) - Recursion Pharma, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in ...

Once upon a time, Apple introduced a new iPhone every year. These days, in some years it introduces five of them. Have we reached saturation point? Possibly. Solution? Ship six iPhones a year. As ...